CTNNB1 and hepatocellular carcinoma: Then in the CHIP experiments by FOXO3 antibody, FOXO3 significantly occupied on the promoter of CTNNB1 in HCC and CRC wild type (WT) cells under the treatment of PS341 (Fig. 6f, top).